Growth Metrics

Novartis Ag (NVS) Depreciation & Amortization (CF) (2016 - 2022)

Historic Depreciation & Amortization (CF) for Novartis Ag (NVS) over the last 14 years, with Q3 2022 value amounting to $2.1 billion.

  • Novartis Ag's Depreciation & Amortization (CF) rose 4636.68% to $2.1 billion in Q3 2022 from the same period last year, while for Jun 2023 it was $2.1 billion, marking a year-over-year decrease of 2835.37%. This contributed to the annual value of $6.9 billion for FY2018, which is 867.02% up from last year.
  • Latest data reveals that Novartis Ag reported Depreciation & Amortization (CF) of $2.1 billion as of Q3 2022, which was up 4636.68% from $1.5 billion recorded in Q1 2022.
  • Novartis Ag's 5-year Depreciation & Amortization (CF) high stood at $2.1 billion for Q3 2022, and its period low was $930.0 million during Q1 2018.
  • Its 5-year average for Depreciation & Amortization (CF) is $1.6 billion, with a median of $1.5 billion in 2022.
  • Per our database at Business Quant, Novartis Ag's Depreciation & Amortization (CF) tumbled by 4763.51% in 2018 and then soared by 5623.66% in 2019.
  • Quarter analysis of 5 years shows Novartis Ag's Depreciation & Amortization (CF) stood at $2.0 billion in 2018, then fell by 28.74% to $1.5 billion in 2019, then fell by 0.28% to $1.4 billion in 2020, then decreased by 0.28% to $1.4 billion in 2021, then soared by 46.37% to $2.1 billion in 2022.
  • Its Depreciation & Amortization (CF) stands at $2.1 billion for Q3 2022, versus $1.5 billion for Q1 2022 and $1.4 billion for Q3 2021.